Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2006, 52, 202-204

https://doi.org/10.14712/fb2006052060202

Depletion of Treg Cells Augments the Therapeutic Effect of Cancer Vaccines

Jan Bubeník

Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Received November 2006
Accepted November 2006

References

1. Attia, P., Maker, A. V., Haworth, L. R., Rogers-Freezer, L., Rosenberg, S. A. (2005) Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J. Immunother. 28, 582-592. <https://doi.org/10.1097/01.cji.0000175468.19742.10>
2. Barnett, B., Kryczek, I., Cheng, P., Zou, W., Curiel, T. J. (2005) Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am. J. Reprod. Immunol. 54, 369-377. <https://doi.org/10.1111/j.1600-0897.2005.00330.x>
3. Berendt, M. J., North, R. J. (1980) T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J. Exp. Med. 151, 69-80. <https://doi.org/10.1084/jem.151.1.69>
4. Bluestone, J. A., Abbas, A. K. (2003) Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257. <https://doi.org/10.1038/nri1032>
5. Bursuker, I., North, R. J. (1984) Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity. J. Exp. Med. 159, 1312-1321. <https://doi.org/10.1084/jem.159.5.1312>
6. Comes, A., Rosso, O., Orengo, A. M., Di Carlo, E., Sorrentino, C., Meazza, R., Piazza, T., Valzasina, B., Nanni, P., Colombo, M. P., Ferrini, S. (2006) CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J. Immunol. 176, 1750-1858. <https://doi.org/10.4049/jimmunol.176.3.1750>
7. Dannull, J., Su, Z., Rizzieri, D., Yang, B. K., Coleman, D., Yancey, D., Zhang, A., Dahm, P., Chao, N., Gilboa, E., Vieweg, J. (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115, 3623-3633. <https://doi.org/10.1172/JCI25947>
8. Elia, L., Aurisicchio, L., Facciabene, A., Giannetti, P., Ciliberto, G., La Monica, N., Palombo, F. (2006) CD4(+)CD25(+) regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge. Cancer Gene Ther., in press.
9. Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336. <https://doi.org/10.1038/ni904>
10. Fujimoto, S., Greene, M., Sehon, A. H. (1975) Immunosuppressor T cells in tumor bearing host. Immunol. Commun. 4, 201-217. <https://doi.org/10.3109/08820137409055774>
11. Gershon, R. K., Kondo, K. (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737.
12. Gershon, R. K., Kondo, K. (1971) Infectious immunological tolerance. Immunology 21, 903-914.
13. Hori, S., Nomura, T., Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. <https://doi.org/10.1126/science.1079490>
14. Kudo-Saito, C., Schlom, J., Camphausen, K., Coleman, C. N., Hodge, J. W. (2005) The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin. Cancer Res. 11, 4533-4544. <https://doi.org/10.1158/1078-0432.CCR-04-2237>
15. Mahic, M., Yaqub, S., Johansson, C. C., Tasken, K., Aandahl, E. M. (2006) FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177, 246-254. <https://doi.org/10.4049/jimmunol.177.1.246>
16. Meloni, F., Morosini, M., Solari, N., Passadore, I., Nascimbene, C., Novo, M., Ferrari, M, Cosentino, M., Marino, F., Pozzi, E., Fietta, A.M. (2006) Foxp3 expressing CD4+ CD25+ and CD8+CD28-T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum. Immunol. 67, 1-12. <https://doi.org/10.1016/j.humimm.2005.11.005>
17. Nagai, H., Horikawa, T., Hara, I., Fukunaga, A., Oniki, S., Oka, M., Nishigori, C., Ichihashi, M. (2004) In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Exp. Dermatol. 13, 613-620. <https://doi.org/10.1111/j.0906-6705.2004.00198.x>
18. North, R. J., Bursuker, I. (1984) Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J. Exp. Med. 159, 1295-1311. <https://doi.org/10.1084/jem.159.5.1295>
19. Prasad, S. J., Farrand, K. J., Matthews, S. A., Chang, J. H., McHugh, R. S., Ronchese, F. (2005) Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells. J. Immunol. 174, 90-98. <https://doi.org/10.4049/jimmunol.174.1.90>
20. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164. <https://doi.org/10.4049/jimmunol.155.3.1151>
21. Šímová, J., Bubeník, J., Bieblová, J., Rosalia, R. A., Frič, J., Reiniš, M. (2006) Depletion of Treg cells inhibits minimal residual disease after surgery of HPV16-associated tumours. Int. J. Oncol. 29, 1567-1571.
22. Viehl, C. T., Moore, T. T., Liyanage, U. K., Frey, D. M., Ehlers, J. P., Eberlein, T. J., Goedegebuure, P. S., Linehan, D. C. (2006) Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann. Surg. Oncol. 13, 1252-1258. <https://doi.org/10.1245/s10434-006-9015-y>
23. Yamaguchi, T., Sakaguchi, S. (2006) Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 16, 115-123. <https://doi.org/10.1016/j.semcancer.2005.11.005>
24. Zou, W. (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307. <https://doi.org/10.1038/nri1806>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive